Article ID Journal Published Year Pages File Type
6189701 Brachytherapy 2013 5 Pages PDF
Abstract
Our study shows that the HDR contribution is 7% (4.00 Gy) of the total EQD2 (57.45 Gy). The HDR contribution should be accounted for when prescribing the EBRT boost dose to pelvic LNs for the optimal therapeutic dose.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer
Authors
, , , ,